Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT)

Q: What does CUSIP 71722W107 represent in this 13F holders report?

CUSIP 71722W107 is the security identifier for PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in Q2 2023?

103 institutional investors reported PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share for Q2 2023. Use the holders table for investor-level position and value details.

CUSIP: 71722W107

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 78,837,943
Total 13F shares: 42,778,866
Share change: +11,992,072
Total reported value: $612,591,768
Put/Call ratio: 20%
Price per share: $14.32
Number of holders: 103
Value change: +$176,400,941
Number of buys: 68
Number of sells: 29

Quarterly Holders Quick Answers

What is CUSIP 71722W107?
CUSIP 71722W107 identifies PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 71722W107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Frazier Life Sciences Management, L.P.	13F	Company	11%	8,407,152	$60,027,065	—	31 Mar 2023	13F
Carlyle Group Inc.	13F	Company	3.7%	2,935,106	$20,868,604	—	31 Mar 2023	13F
Medicxi Ventures Management (Jersey) Ltd	13F	Company	3.2%	2,484,274	$17,737,716	—	31 Mar 2023	13F
Invesco Ltd.	13F	Company	2.8%	2,181,672	$15,577,139	—	31 Mar 2023	13F
Avidity Partners Management LP	13F	Company	2.6%	2,048,600	$14,627,004	—	31 Mar 2023	13F
Ensign Peak Advisors, Inc	13F	Company	2.2%	1,761,191	$12,574,903	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	2.1%	1,632,910	$11,658,979	—	31 Mar 2023	13F
683 Capital Management, LLC	13F	Company	1.7%	1,325,500	$9,464,071	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	1.5%	1,177,497	$8,407,329	—	31 Mar 2023	13F
Newtyn Management, LLC	13F	Company	0.87%	682,027	$4,869,673	—	31 Mar 2023	13F
GW&K Investment Management, LLC	13F	Company	0.76%	598,848	$4,276,000	—	31 Mar 2023	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.7%	553,829	$3,954,339	—	31 Mar 2023	13F
Opaleye Management Inc.	13F	Company	0.63%	496,000	$3,541,440	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	0.59%	463,743	$3,311,125	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.57%	448,611	$3,203,082	—	31 Mar 2023	13F
StepStone Group LP	13F	Company	0.54%	422,085	$3,013,687	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.32%	253,485	$1,809,883	—	31 Mar 2023	13F
Simplify Asset Management Inc.	13F	Company	0.3%	237,935	$1,698,856	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.27%	212,901	$1,520,114	—	31 Mar 2023	13F
MPM BioImpact LLC	13F	Company	0.27%	212,615	$1,518,071	—	31 Mar 2023	13F
SILVERARC CAPITAL MANAGEMENT, LLC	13F	Company	0.25%	200,000	$1,428,000	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.24%	188,484	$1,345,775	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.22%	171,607	$1,225,274	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.19%	146,416	$1,045,410	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.17%	133,587	$954,000	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.14%	108,284	$773,000	—	31 Mar 2023	13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)	13F	Company	0.13%	100,093	$714,664	—	31 Mar 2023	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.12%	95,167	$679,492	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.12%	93,698	$669,003	—	31 Mar 2023	13F
Atom Investors LP	13F	Company	0.11%	86,607	$618,374	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.1%	77,337	$552,187	—	31 Mar 2023	13F
Penn Mutual Asset Management	13F	Company	0.08%	62,802	$448,406	—	31 Mar 2023	13F
S.c.a. Candriam	13F	Individual	0.08%	63,778	$419,140	—	31 Mar 2023	13F
Hennion & Walsh Asset Management, Inc.	13F	Company	0.07%	58,042	$414,000	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.07%	57,863	$413,000	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.06%	48,681	$347,583	—	31 Mar 2023	13F
Swiss National Bank	13F	Company	0.05%	40,400	$288,456	—	31 Mar 2023	13F
MARSHALL WACE, LLP	13F	Company	0.05%	37,096	$264,866	—	31 Mar 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.04%	32,761	$234,000	—	31 Mar 2023	13F
Occidental Asset Management, LLC	13F	Company	0.04%	29,672	$211,858	—	31 Mar 2023	13F
SIMPLEX TRADING, LLC	13F	Company	0.04%	29,411	$209,000	—	31 Mar 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.04%	29,100	$207,774	—	31 Mar 2023	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.03%	27,300	$194,922	—	31 Mar 2023	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.03%	25,530	$182,284	—	31 Mar 2023	13F
INSPIRION WEALTH ADVISORS, LLC	13F	Company	0.03%	23,249	$165,998	—	31 Mar 2023	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.03%	20,232	$144,000	—	31 Mar 2023	13F
Creative Planning	13F	Company	0.03%	20,000	$142,800	—	31 Mar 2023	13F
Allworth Financial LP	13F	Company	0.02%	19,580	$139,802	—	31 Mar 2023	13F
CREDIT SUISSE AG/	13F	Company	0.02%	16,661	$118,960	—	31 Mar 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.02%	16,199	$115,661	—	31 Mar 2023	13F

Institutional Holders of Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT) as of Q2 2023

As of 30 Jun 2023, Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT) was held by 103 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 42,778,866 shares. The largest 10 holders included Frazier Life Sciences Management, L.P., Medicxi Ventures Management (Jersey) Ltd, Carlyle Group Inc., Invesco Ltd., BlackRock Inc., Avidity Partners Management LP, Ensign Peak Advisors, Inc, VANGUARD GROUP INC, 683 Capital Management, LLC, and NEA Management Company, LLC. This page lists 103 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

103

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.